Sept. 8, 2023, 5:45 p.m. | Globe Newswire

AI – AI-TechPark ai-techpark.com

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announce a multi-target collaboration to develop intravitreally-delivered adeno-associated viruses (AAVs) for ocular diseases, with options to add additional targets and tissue types. The companies will collaborate to apply ShapeTX’s AAVid™ capsid...


The post Otsuka collaborates with ShapeTX first appeared on AI-TechPark.

ai apply collaboration companies diseases medicine pharmaceutical rna targets types viruses

AI Research Scientist

@ Vara | Berlin, Germany and Remote

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Data Analyst (Digital Business Analyst)

@ Activate Interactive Pte Ltd | Singapore, Central Singapore, Singapore